SHPMY Stock Shanghai Pharmaceuticals Holdings (SHPMY, $7.4) RSI Indicator left the oversold zone on September 16, 2025

GET DAILY SIGNALS

Get AI intraday signals

SHPMY - Shanghai Pharmaceuticals Holdings Co., Ltd.

RSI signal

View

Odds of UP Trend

Price: $7.4

Daily change: -$0.9 (-10.84%)

Daily volume: 236

Capitalization: $8.5B

Industry: Medical Distributors

SHPMY sees its 50-day moving average cross bullishly above its 200-day moving average

The 50-day moving average for SHPMY moved above the 200-day moving average on August 26, 2025. This could be a long-term bullish signal for the stock as the stock shifts to an upward trend.

Technical Analysis (Indicators)

Bullish Trend Analysis

The RSI Oscillator points to a transition from a downward trend to an upward trend -- in cases where SHPMY's RSI Indicator exited the oversold zone, of 28 resulted in an increase in price. Tickeron's analysis proposes that the odds of a continued upward trend are .

The Momentum Indicator moved above the 0 level on September 24, 2025. You may want to consider a long position or call options on SHPMY as a result. In of 101 past instances where the momentum indicator moved above 0, the stock continued to climb. The odds of a continued upward trend are .

The Moving Average Convergence Divergence (MACD) for SHPMY just turned positive on September 25, 2025. Looking at past instances where SHPMY's MACD turned positive, the stock continued to rise in of 59 cases over the following month. The odds of a continued upward trend are .

SHPMY moved above its 50-day moving average on September 24, 2025 date and that indicates a change from a downward trend to an upward trend.

SHPMY may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Bearish Trend Analysis

The Stochastic Oscillator entered the overbought zone. Expect a price pull-back in the foreseeable future.

The 10-day moving average for SHPMY crossed bearishly below the 50-day moving average on September 22, 2025. This indicates that the trend has shifted lower and could be considered a sell signal. In of 15 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

The Aroon Indicator for SHPMY entered a downward trend on September 03, 2025. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Fundamental Analysis (Ratings)

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. SHPMY’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is slightly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.585) is normal, around the industry mean (9.737). P/E Ratio (7.220) is within average values for comparable stocks, (28.788). SHPMY's Projected Growth (PEG Ratio) (5.146) is slightly higher than the industry average of (2.527). Dividend Yield (0.031) settles around the average of (0.031) among similar stocks. P/S Ratio (0.158) is also within normal values, averaging (141.860).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. SHPMY’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 84, placing this stock better than average.